NICE has begun consulting on draft guidance that could recommend four specialist liver preservation machines for routine NHS use, in a move that may help more people waiting for life-saving transplants. The proposal, published on 20 May 2026, is aimed at improving the chances of using donor livers that would otherwise be more difficult to transplant safely.
What the guidance could change for transplant care
According to NICE, the machines are designed to keep donor livers alive outside the body, potentially giving clinicians more time to assess and prepare organs before surgery. The consultation comes as part of efforts to improve outcomes for the estimated 600 people in England currently waiting for a liver transplant. ([nice.org.uk](https://www.nice.org.uk/news/articles?utm_source=openai))
The new recommendation does not mean immediate nationwide adoption, but it signals a possible shift in how transplant centres could preserve and use donor organs. NICE said the technology could help more patients receive a transplant by increasing the number of livers suitable for use. ([nice.org.uk](https://www.nice.org.uk/news/articles?utm_source=openai))
Why the technology matters
Liver transplants remain a high-stakes procedure, and the availability of suitable donor organs is a persistent challenge. By keeping livers functioning outside the body for longer, preservation machines may give specialists additional flexibility in deciding whether an organ is fit for transplant and how best to match it to a recipient. That could translate into more opportunities for patients who are waiting for treatment. ([nice.org.uk](https://www.nice.org.uk/news/articles?utm_source=openai))
NICE said the consultation is now open on its draft guidance, meaning clinicians, hospitals and other stakeholders can review the proposal before a final decision is made. If approved, the machines would be considered for routine NHS use, extending access beyond specialist or limited settings. ([nice.org.uk](https://www.nice.org.uk/news/articles?utm_source=openai))
Part of a wider wave of NHS innovation
The announcement follows a series of recent NICE decisions and draft recommendations across major treatment areas, including neonatal infection care, spinal muscular atrophy, and aggressive stomach cancer. Together, these updates suggest a continued focus on therapies and technologies that can shorten hospital stays, expand access to treatment and improve survival for patients with serious conditions. ([nice.org.uk](https://www.nice.org.uk/news/articles/nice-updates-neonatal-infection-guidance-to-allow-home-antibiotic-treatment-for-some-babies?utm_source=openai))
For liver patients and transplant teams, the key question now is whether the final guidance will support routine use of the machines across the NHS. If it does, the change could offer a practical route to improving transplant capacity at a time when demand remains high and every viable organ matters. ([nice.org.uk](https://www.nice.org.uk/news/articles?utm_source=openai))
